<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="editorial"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">30517249</article-id><article-id pub-id-type="pmc">6257530</article-id><article-id pub-id-type="doi">10.21470/1678-9741-2018-0329</article-id><article-id pub-id-type="other">00002</article-id><article-categories><subj-group subj-group-type="heading"><subject>Editorial</subject></subj-group></article-categories><title-group><article-title>Coronary Artery Bypass Grafting in Acute Ischemic Heart Failure:
Where do We Stand? (And Where Should We Go?)</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kubrusly</surname><given-names>Fernando B.</given-names></name><role>MD</role><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Machado-Junior</surname><given-names>Paulo Andr&#x000e9; Bispo</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><aff id="aff1">
<label>1</label> Incor Curitiba, Instituto Denton Cooley, Hospital do
Cora&#x000e7;&#x000e3;o de Curitiba, Curitiba, PR, Brazil.</aff><aff id="aff2">
<label>2</label> Escola de Medicina, Pontif&#x000ed;cia Universidade
Cat&#x000f3;lica do Paran&#x000e1; (PUCPR), Curitiba, PR, Brazil.</aff></contrib-group><pub-date pub-type="epub-ppub"><season>Sep-Oct</season><year>2018</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Sep-Oct</season><year>2018</year></pub-date><volume>33</volume><issue>5</issue><fpage>II</fpage><lpage>III</lpage><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions></article-meta></front><body><p>Acute heart failure (AHF) refers to rapid onset or worsening of signs and symptoms of
heart failure, often requiring hospitalization and urgent treatment, due to its
potentially life-threatening condition<sup>[<xref rid="r1" ref-type="bibr">1</xref>]</sup>. The vast-majority of patients that suffers from heart failure has
acute worsening episodes that become more frequent as the disease progresses.</p><p>More than half of these patients are known to have an ischemic etiology, and early
revascularization improve clinical outcomes<sup>[<xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r3" ref-type="bibr">3</xref>]</sup>, and the immediate
invasive strategy with intent to perform revascularization in patients with both AHF and
acute coronary syndrome is recommended in guidelines<sup>[<xref rid="r4" ref-type="bibr">4</xref>,<xref rid="r5" ref-type="bibr">5</xref>]</sup>. However, the choices
of revascularization are still controversial subject: either percutaneous coronary
intervention (PCI) or coronary artery bypass grafting (CABG).</p><p>Which one is better has been long debated. Trials comparing both techniques have shown
that the rates of most adverse clinical outcomes favor CABG, which turns this technique
as the preferred revascularization strategy in patients with multivessel disease.
Unfortunately, most of the trials comparing PCI versus CABG were designed in the setting
of stable coronary artery disease. The majority of patients included in these studies
had two vessel disease and preserved left ventricular function, differing from the
patients with AHF. Even so, there&#x02019;s still no evidence of survival improvement when PCI
was compared to CABG, especially in the long-term comparison.</p><p>A recent multicenter prospective cohort study, The Korean Acute Heart Failure Registry,
evaluated 5625 patients enrolled prospectively from March 2011 to February
2014<sup>[<xref rid="r6" ref-type="bibr">6</xref>]</sup>. In this analysis, 717
patients received CABG or PCI during the hospitalization for AHF. Adverse outcomes
(death, ischemic stroke and a composite outcome of death and readmission for heart
failure worsening or cardiovascular causes) were used for propensity score matching. The
authors concluded that, compared to PCI, CABG was associated with significant lower
all-cause mortality in patients with AHF. The rate of death from any cause over 4 years
was lowered by 40% among patients who underwent CABG than those who received PCI. These
are very impressive results.</p><p>Another recent multicenter observational analysis between 2004 and 2014 among 7 medical
centers, reporting to the Northern New England Cardiovascular Disease Study group,
evaluated more than 70,000 patients who underwent CABG (n=18,292) versus PCI
(n=55,438)<sup>[<xref rid="r7" ref-type="bibr">7</xref>]</sup>. After applying
inclusion and exclusion criteria from the Surgical Treatment for Ischemic Heart Failure
trial, the study showed that CABG was associated with improved long-term survival when
compared to PCI in patients with ejection &#x02264; 35% and 2- or 3-vessel disease. In
the long-term analysis, CABG was associated with lower incidence of all-cause mortality,
being CABG strongly considered in these patients with ischemic cardiomyopathy and
multivessel coronary disease.</p><p>The better results for surgery might be attributable to the ability to achieve complete
revascularization in extensive coronary artery disease<sup>[<xref rid="r8" ref-type="bibr">8</xref>]</sup>. The complete revascularization rate, defined as all
stenotic main-branch vessels being treated<sup>[<xref rid="r9" ref-type="bibr">9</xref>]</sup>, is always significantly higher in the CABG group than in the PCI
group in most studies.</p><p>PCI is a well-established strategy and the advance and progress of the stents is beyond
question. However, for patients that are experiencing signs and symptoms of heart
failure, surgery is still the best and safer option. Besides, after 50 years the
surgical field has also innovated and advanced. The use of multiple arterial grafts that
have superior long-term patency has significantly improved the survival rates. Also,
off-pump surgery has reduced aortic manipulation and consequently the rates of stroke
and heart failure after surgery on specific patients.</p><p>It is unquestionable and a very widely known (but unfortunately not always remembered)
fact that CABG yields better results and therefore a better and longer life ahead for
these patients.</p></body><back><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ponikowski</surname><given-names>P</given-names></name><name><surname>Voors</surname><given-names>AA</given-names></name><name><surname>Anker</surname><given-names>SD</given-names></name><name><surname>Bueno</surname><given-names>H</given-names></name><name><surname>Cleland</surname><given-names>JGF</given-names></name><name><surname>Coats</surname><given-names>AJS</given-names></name><etal/></person-group><article-title>2016 ESC Guidelines for the diagnosis and treatment of acute and
chronic heart failure: The Task Force for the diagnosis and treatment of
acute and chronic heart failure of the European Society of Cardiology (ESC)
Developed with the special contribution of the Heart Failure Association
(HFA) of the ESC</article-title><source>Eur Heart J</source><year>2016</year><volume>37</volume><issue>27</issue><fpage>2129</fpage><lpage>2200</lpage><pub-id pub-id-type="pmid">27206819</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tavazzi</surname><given-names>L</given-names></name><name><surname>Maggioni</surname><given-names>AP</given-names></name><name><surname>Lucci</surname><given-names>D</given-names></name><name><surname>Cacciatore</surname><given-names>G</given-names></name><name><surname>Ansalone</surname><given-names>G</given-names></name><name><surname>Oliva</surname><given-names>F</given-names></name><etal/></person-group><article-title>Nationwide survey on acute heart failure in cardiology ward
services in Italy</article-title><source>Eur Heart J</source><year>2006</year><volume>27</volume><issue>10</issue><fpage>1207</fpage><lpage>1215</lpage><pub-id pub-id-type="pmid">16603579</pub-id></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rossi</surname><given-names>JS</given-names></name><name><surname>Flaherty</surname><given-names>JD</given-names></name><name><surname>Fonarow</surname><given-names>GC</given-names></name><name><surname>Nunez</surname><given-names>E</given-names></name><name><surname>Gattis Stough</surname><given-names>W</given-names></name><name><surname>Abraham</surname><given-names>WT</given-names></name><etal/></person-group><article-title>Influence of coronary artery disease and coronary
revascularization status on outcomes in patients with acute heart failure
syndromes: a report from OPTIMIZE-HF (Organized Program to Initiate
Lifesaving Treatment in Hospitalized Patients with Heart
Failure)</article-title><source>Eur J Heart Fail</source><year>2008</year><volume>10</volume><issue>12</issue><fpage>1215</fpage><lpage>1223</lpage><pub-id pub-id-type="pmid">19006680</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sliwa</surname><given-names>K</given-names></name><name><surname>Davison</surname><given-names>BA</given-names></name><name><surname>Mayosi</surname><given-names>BM</given-names></name><name><surname>Damasceno</surname><given-names>A</given-names></name><name><surname>Sani</surname><given-names>M</given-names></name><name><surname>Ogah</surname><given-names>OS</given-names></name><etal/></person-group><article-title>Readmission and death after an acute heart failure event:
predictors and outcomes in sub-Saharan Africa: results from the THESUS-HF
registry</article-title><source>Eur Heart J</source><year>2013</year><volume>34</volume><issue>40</issue><fpage>3151</fpage><lpage>3159</lpage><pub-id pub-id-type="pmid">24048728</pub-id></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amsterdam</surname><given-names>EA</given-names></name><name><surname>Wenger</surname><given-names>NK</given-names></name><name><surname>Brindis</surname><given-names>RG</given-names></name><name><surname>Casey</surname><given-names>DE Jr</given-names></name><name><surname>Ganiats</surname><given-names>TG</given-names></name><name><surname>Holmes</surname><given-names>DR Jr</given-names></name><etal/></person-group><article-title>2014 AHA/ACC Guideline for the management of patients with
non-ST-elevation acute coronary syndromes: a report of the American College
of Cardiology/American Heart Association Task Force on Practice
Guidelines</article-title><source>J Am Coll Cardiol</source><year>2014</year><volume>64</volume><issue>24</issue><fpage>e139</fpage><lpage>e228</lpage><pub-id pub-id-type="pmid">25260718</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>SE</given-names></name><name><surname>Lee</surname><given-names>HY</given-names></name><name><surname>Cho</surname><given-names>HJ</given-names></name><name><surname>Choe</surname><given-names>WS</given-names></name><name><surname>Kim</surname><given-names>H</given-names></name><name><surname>Choi</surname><given-names>JO</given-names></name><etal/></person-group><article-title>Coronary artery bypass graft versus percutaneous coronary
intervention in acute heart failure</article-title><source>Heart</source><year>2018</year><!--<pub-id pub-id-type="pii">heartjnl-2018-313242</pub-id>--></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iribarne</surname><given-names>A</given-names></name><name><surname>DiScipio</surname><given-names>AW</given-names></name><name><surname>Leavitt</surname><given-names>BJ</given-names></name><name><surname>Baribeau</surname><given-names>YR</given-names></name><name><surname>McCullough</surname><given-names>JN</given-names></name><name><surname>Weldner</surname><given-names>PW</given-names></name><etal/></person-group><article-title>Comparative effectiveness of coronary artery bypass grafting
versus percutaneous coronary intervention in a real-world Surgical Treatment
for Ischemic Heart Failure trial population</article-title><source>J Thorac Cardiovasc Surg</source><year>2018</year><volume>156</volume><issue>4</issue><fpage>1410</fpage><lpage>1421</lpage><pub-id pub-id-type="pmid">29961592</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahn</surname><given-names>J</given-names></name><name><surname>Park</surname><given-names>D</given-names></name><name><surname>Lee</surname><given-names>CW</given-names></name><name><surname>Chang</surname><given-names>M</given-names></name><name><surname>Cavalcante</surname><given-names>R</given-names></name><name><surname>Sotomi</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Comparison of stenting versus bypass surgery according to the
completeness of revascularization in severe coronary artery disease:
patient-level pooled analysis of the SYNTAX, PRECOMBAT, and BEST
trials</article-title><source>JACC Cardiovasc Interv</source><year>2017</year><volume>10</volume><issue>14</issue><fpage>1415</fpage><lpage>1424</lpage><pub-id pub-id-type="pmid">28728654</pub-id></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>G&#x000f6;ssl</surname><given-names>M</given-names></name><name><surname>Faxon</surname><given-names>DP</given-names></name><name><surname>Bell</surname><given-names>MR</given-names></name><name><surname>Holmes</surname><given-names>DR</given-names></name><name><surname>Gersh</surname><given-names>BJ</given-names></name></person-group><article-title>Complete versus incomplete revascularization with coronary artery
bypass graft or percutaneous intervention in stable coronary artery
disease</article-title><source>Circ Cardiovasc Interv</source><year>2012</year><volume>5</volume><issue>4</issue><fpage>597</fpage><lpage>604</lpage><pub-id pub-id-type="pmid">22896575</pub-id></element-citation></ref></ref-list></back></article>